New studies

New Reference Values for Intracranial Pressure

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 20, 2018.

Condition:   Intracranial Pressure
Intervention:   Device: Raumedic Neurovent-P-tel
Sponsors:   Rigshospitalet, Denmark;   Lundbeck Foundation
Recruiting

Additional Hyperbaric Oxygen After Lower Extremity Amputation

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 20, 2018.

Conditions:   Diabetes Mellitus;   Claudication, Intermittent;   Critical Limb Ischemia;   Osteomyelitis;   Amputation;   Lower Extremity Ulcer;   Diabetic Angiopathy;   Diabetic Neuropathies;   Diabetic Foot
Intervention:   Procedure: Hyperbaric oxygen therapy
Sponsor:   Oslo University Hospital
Recruiting

The Effect of Lifestyle Treatment in Patients With Morbid Obesity

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 19, 2018.

Conditions:   Physical Capacity;   Leg Strength;   Eating Behavior;   Life of Quality
Intervention:   Other: Lifestyle
Sponsors:   Sykehuset i Vestfold HF;   University college of south-east Norway
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 18, 2018.

Condition:   Acute Lymphoblastic Leukemia (ALL)
Intervention:   Drug: Bortezomib
Sponsors:   Charite University, Berlin, Germany;   Australian & New Zealand Childhood Hematology & Oncology Group (Co-Sponsor Australia/NZ);   St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria);   EORTC (Co-Sponsor Belgium);   University Hospital Motol (Co-Sponsor Czech Republic);   Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark);   Turku University Central Hospital (co-sponsor, Finland);   CHU de NICE, Hôpital L'ARCHET (co-sponsor, France);   Our Lady's Chilrden's Hospital (Co-Sponsor Ireland);   Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel);   Ospedale Pediatrico Bambino (co-sponsor, Italy);   Prinses Máxima Centrum (Co-Sponsor Netherlands);   Oslo University Hospital (co-sponsor, Norway);   Medical University of Wroclaw (Co-Sponsor Poland);   Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal);   Karolinska University Hospital Stockholm (co-sponsor, Sweden);   Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain);   University Children's Hospital Zürich (co-sponsor, Switzerland);   Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

From ClinicalTrials.gov: Recruiting Studies | Finland | First posted in the last 14 days. Published on Jul 18, 2018.

Condition:   Acute Lymphoblastic Leukemia (ALL)
Intervention:   Drug: Bortezomib
Sponsors:   Charite University, Berlin, Germany;   Australian & New Zealand Childhood Hematology & Oncology Group (Co-Sponsor Australia/NZ);   St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria);   EORTC (Co-Sponsor Belgium);   University Hospital Motol (Co-Sponsor Czech Republic);   Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark);   Turku University Central Hospital (co-sponsor, Finland);   CHU de NICE, Hôpital L'ARCHET (co-sponsor, France);   Our Lady's Chilrden's Hospital (Co-Sponsor Ireland);   Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel);   Ospedale Pediatrico Bambino (co-sponsor, Italy);   Prinses Máxima Centrum (Co-Sponsor Netherlands);   Oslo University Hospital (co-sponsor, Norway);   Medical University of Wroclaw (Co-Sponsor Poland);   Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal);   Karolinska University Hospital Stockholm (co-sponsor, Sweden);   Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain);   University Children's Hospital Zürich (co-sponsor, Switzerland);   Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 18, 2018.

Condition:   Acute Lymphoblastic Leukemia (ALL)
Intervention:   Drug: Bortezomib
Sponsors:   Charite University, Berlin, Germany;   Australian & New Zealand Childhood Hematology & Oncology Group (Co-Sponsor Australia/NZ);   St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria);   EORTC (Co-Sponsor Belgium);   University Hospital Motol (Co-Sponsor Czech Republic);   Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark);   Turku University Central Hospital (co-sponsor, Finland);   CHU de NICE, Hôpital L'ARCHET (co-sponsor, France);   Our Lady's Chilrden's Hospital (Co-Sponsor Ireland);   Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel);   Ospedale Pediatrico Bambino (co-sponsor, Italy);   Prinses Máxima Centrum (Co-Sponsor Netherlands);   Oslo University Hospital (co-sponsor, Norway);   Medical University of Wroclaw (Co-Sponsor Poland);   Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal);   Karolinska University Hospital Stockholm (co-sponsor, Sweden);   Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain);   University Children's Hospital Zürich (co-sponsor, Switzerland);   Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Recruiting

Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC

From ClinicalTrials.gov: Recruiting Studies | Sweden | First posted in the last 14 days. Published on Jul 18, 2018.

Conditions:   Mrk Anomaly;   Infertility, Female
Intervention:   Procedure: uterus transplantation surgery and IVF
Sponsors:   Sahlgrenska University Hospital, Sweden;   Saint Joseph University, at Bellevue Medical Centre
Recruiting

International Study for Treatment of High Risk Childhood Relapsed ALL 2010

From ClinicalTrials.gov: Recruiting Studies | Sweden | First posted in the last 14 days. Published on Jul 18, 2018.

Condition:   Acute Lymphoblastic Leukemia (ALL)
Intervention:   Drug: Bortezomib
Sponsors:   Charite University, Berlin, Germany;   Australian & New Zealand Childhood Hematology & Oncology Group (Co-Sponsor Australia/NZ);   St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria);   EORTC (Co-Sponsor Belgium);   University Hospital Motol (Co-Sponsor Czech Republic);   Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark);   Turku University Central Hospital (co-sponsor, Finland);   CHU de NICE, Hôpital L'ARCHET (co-sponsor, France);   Our Lady's Chilrden's Hospital (Co-Sponsor Ireland);   Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel);   Ospedale Pediatrico Bambino (co-sponsor, Italy);   Prinses Máxima Centrum (Co-Sponsor Netherlands);   Oslo University Hospital (co-sponsor, Norway);   Medical University of Wroclaw (Co-Sponsor Poland);   Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal);   Karolinska University Hospital Stockholm (co-sponsor, Sweden);   Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain);   University Children's Hospital Zürich (co-sponsor, Switzerland);   Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Recruiting

A Clinical Validation Study of a Computerized Movement Analysis of the Colonoscope

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 16, 2018.

Condition:   Colonoscopy
Interventions:   Other: 3D-Colonoscopy Progression Score;   Other: 3D-Colonoscopy Retraction Score
Sponsors:   Rigshospitalet, Denmark;   Technical University of Denmark
Recruiting

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

From ClinicalTrials.gov: Recruiting Studies | Sweden | First posted in the last 14 days. Published on Jul 16, 2018.

Condition:   Alzheimer Disease
Intervention:   Drug: Atabecestat
Sponsor:   Janssen Research & Development, LLC
Recruiting

Evaluation of the Ear-EEG System for Sleep Monitoring in Healthy Subjects

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 13, 2018.

Condition:   Sleep Monitoring
Intervention:   Device: ear-EEG
Sponsors:   University of Aarhus;   Uneeg medical
Recruiting

Treatment of Chronic Postherpetic Pain With Fat Grafting

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 12, 2018.

Conditions:   Post Herpetic Neuralgia;   Herpes Zoster
Intervention:   Procedure: Fat grafting
Sponsor:   Odense University Hospital
Recruiting

Biomarkers in Acute High-risk AbdoMinAl Surgery

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 11, 2018.

Conditions:   General Surgery;   Inflammation;   Troponins;   Biomarkers
Intervention:   Procedure: Emergency abdominal surgery
Sponsors:   University of Copenhagen;   Hvidovre University Hospital
Recruiting

Coronary Artery Disease After Heart Transplantation

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 11, 2018.

Conditions:   Coronary Artery Disease in Transplanted Heart (Diagnosis);   Platelet Dysfunction
Interventions:   Drug: Aspirin 75mg;   Other: Extracorporeal photopheresis
Sponsor:   Aarhus University Hospital
Recruiting

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

From ClinicalTrials.gov: Recruiting Studies | Denmark | First posted in the last 14 days. Published on Jul 10, 2018.

Condition:   Mucositis
Interventions:   Drug: Folic Acid;   Drug: Placebo Oral Tablet
Sponsor:   Frede Donskov
Recruiting

De-labeling of Patients With False Diagnosis of Penicillin Allergy

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 10, 2018.

Condition:   Allergy Drug
Interventions:   Diagnostic Test: Allergy work-up;   Other: Blood samples and microbiological samples.
Sponsor:   Oslo University Hospital
Recruiting

Effect of Weight Loss and Lactation (the EVA-trial)

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 09, 2018.

Condition:   Cardiovascular Risk Factor
Interventions:   Behavioral: Breastfeeding promotion intervention;   Behavioral: Diet and weight loss intervention
Sponsor:   University of Oslo
Recruiting

Hand Therapy or Not Following Collagenase Treatment for Dupuytren's Contracture?

From ClinicalTrials.gov: Recruiting Studies | Norway | First posted in the last 14 days. Published on Jul 09, 2018.

Condition:   Dupuytren Disease of Palm and Finger, With Contracture
Interventions:   Other: Hand therapy MCPJ affected;   Other: Hand therapy PIPJ affected
Sponsor:   Haukeland University Hospital
Recruiting